MKGAY: Analysis & Opinions

  1.

    Oncothyreon/Merck KGaA Drug Fails - Analyst Blog

    December 27, 2012
    Oncothyreon Inc. (ONTY) and its partner, Merck KGaA (MKGAY) recently presented disappointing data from a phase III ...
  2.

    Biogen Idec Has Built A Valuable Franchise

    November 01, 2011
    Biogen Idec is a go-to name in MS that carries a lot of value. A credible buy for those with longer horizons.
Marketplace
Trading Center